scholarly journals Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

2017 ◽  
Vol 5 (3) ◽  
pp. e324-e334 ◽  
Author(s):  
Jing-Xin Li ◽  
Li-Hua Hou ◽  
Fan-Yue Meng ◽  
Shi-Po Wu ◽  
Yue-Mei Hu ◽  
...  
Keyword(s):  
Recombinant Adenovirus ◽  
Phase 1 ◽  
Adenovirus Type ◽  
Healthy Adults ◽  
Final Report ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Trial ◽  
Adenovirus Type 5

scholarly journals H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

2016 ◽  
Vol 16 (3) ◽  
pp. 303-310 ◽  
Author(s):  
Larisa Rudenko ◽  
Irina Isakova-Sivak ◽  
Anatoly Naykhin ◽  
Irina Kiseleva ◽  
Marina Stukova ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Phase 1 ◽  
Healthy Adults ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Trial ◽  
Live Attenuated Influenza Vaccine
Sign in / Sign up

Export Citation Format

Share Document